05:18 PM EDT, 05/14/2025 (MT Newswires) -- Mark E Delaney, Senior Vice President & Chief Commercial Officer, on May 12, 2025, sold 1,748 shares in Quest Diagnostics ( DGX ) for $306,800. Following the Form 4 filing with the SEC, Delaney has control over a total of 7,498 common shares of the company, with 7,498 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1022079/000102207925000132/xslF345X05/wk-form4_1747257144.xml